Niro Ramachandran - Apr 13, 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Business Officer
Signature
/s/ Niro Ramachandran, Ph.D., by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Apr 13, 2022
Transactions value $
$68,347
Form type
4
Date filed
4/14/2022, 03:23 PM
Previous filing
Mar 25, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Options Exercise $68.3K +75.1K +157.88% $0.91* 123K Apr 13, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Employee Stock Option (Right to Buy) Options Exercise $0 -75.1K -43.75% $0.00 96.6K Apr 13, 2022 Common Stock 75.1K $0.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as follows: one-fourth (1/4) of the shares on July 13, 2021 and the remaining shares shall vest in 36 equal monthly installments beginning on July 13, 2021, until fully vested, subject to reporting person's continuous employment